chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: FLU3
Symptoms: Rash, Urticaria
Clinical narrative: A report was received from a health care professional on 24 October 2003 concerning an octogenarian female who experienced rash and hives on her face and back of her neck 2 days after receiving Fluvirin on 20 October 2003. On 22 October 2003 the vaccinee experienced rash and hives on her face and back of her neck. On 24 October 2003 the vaccinee presented to a doctor's office and was prescribed loratadine, diphenhydramine hydrochloride, and prednisone (if condition worsened). The vaccinee had no known drug allergies and received the influenza vaccine in the past with out any problems. The vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 27 November 2003: Follow-up information received from a health care professional indicated the the 75 year old vaccinee recovered after three weeks.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 24 October 2003 concerning a 2 year old male vaccinee who inadvertently received Fluvirin on 21 October 2003. On 21 October a two year old vaccinee inadvertently received Fluvirin. The vaccinee did not complain of any adverse event at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 06 February 2004: A follow-up report was received from a health care professional indicating that the vaccinee had experienced no adverse events. No follow-up pending, all information received.
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Pyrexia
Clinical narrative: A report was received from a health care professional who was also the consumer on 24 October 2003 concerning a female vaccinee of an unspecified age who experienced fever and injection site soreness 3 hours and 15 minutes after receiving Fluvirin on 24 October 2003. At 12.15 on 24 October 2003, the vaccinee experienced fever of approximately 99.9 degrees Fahrenheit and soreness in her upper extremity at the injection site. The outcome of the events were not reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Drug ineffective, Headache, Influenza, Influenza like illness
Clinical narrative: A report was received from a consumer on 10/24/2003 concerning a 54 year old vaccinee who experienced flu like symptoms with bad headache, fever, muscle aches, cramps weakness, congestion, sneezing, stiff neck and stiff should 1 day after receiving Fluvirin on 10/10/03. On 10/11/03 the vaccinee experienced flu like symptoms with bad headache, fever muscle aches, cramps, weakness, congestion sneezing, stiff neck and stiff shoulder. At the time of the report the vaccinee continued to have a headache, weakness, congestion and sneezing. the vaccinee took diphenhydramine hydrochloride and aspirin for relief of symptoms, neither of which was very effective. The vaccinee had not recovered at the time of the report. Update 1, 03/30/2004: a follow up report was received from a consumer indicating that he had experienced influenza, coughing and a stiff neck/shoulder almost continually since receiving Fluvirin on 10/10/2003. On 3/4/2004, the vaccinee attended an emergency room for chest pain du to excessive coughing. The reporter indicated that the doctor came to the conclusion that the vaccinee's chest wall had gone into spasm due to coughing. The vaccinee also attended a doctor on 02/19/2004 for should spasm and pain. Update 2, 05/11/2004: A follow up report was received from a health care professional indicating that he had seen the vaccinee in the emergency room for other reasons. Follow up pending.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Muscle spasms, Musculoskeletal stiffness, Myalgia, Nasal congestion, Pyrexia
Clinical narrative: A report was received from a consumer on 10/24/2003 concerning a 54 year old vaccinee who experienced flu like symptoms with bad headache, fever, muscle aches, cramps weakness, congestion, sneezing, stiff neck and stiff should 1 day after receiving Fluvirin on 10/10/03. On 10/11/03 the vaccinee experienced flu like symptoms with bad headache, fever muscle aches, cramps, weakness, congestion sneezing, stiff neck and stiff shoulder. At the time of the report the vaccinee continued to have a headache, weakness, congestion and sneezing. the vaccinee took diphenhydramine hydrochloride and aspirin for relief of symptoms, neither of which was very effective. The vaccinee had not recovered at the time of the report. Update 1, 03/30/2004: a follow up report was received from a consumer indicating that he had experienced influenza, coughing and a stiff neck/shoulder almost continually since receiving Fluvirin on 10/10/2003. On 3/4/2004, the vaccinee attended an emergency room for chest pain du to excessive coughing. The reporter indicated that the doctor came to the conclusion that the vaccinee's chest wall had gone into spasm due to coughing. The vaccinee also attended a doctor on 02/19/2004 for should spasm and pain. Update 2, 05/11/2004: A follow up report was received from a health care professional indicating that he had seen the vaccinee in the emergency room for other reasons. Follow up pending.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Sneezing
Clinical narrative: A report was received from a consumer on 10/24/2003 concerning a 54 year old vaccinee who experienced flu like symptoms with bad headache, fever, muscle aches, cramps weakness, congestion, sneezing, stiff neck and stiff should 1 day after receiving Fluvirin on 10/10/03. On 10/11/03 the vaccinee experienced flu like symptoms with bad headache, fever muscle aches, cramps, weakness, congestion sneezing, stiff neck and stiff shoulder. At the time of the report the vaccinee continued to have a headache, weakness, congestion and sneezing. the vaccinee took diphenhydramine hydrochloride and aspirin for relief of symptoms, neither of which was very effective. The vaccinee had not recovered at the time of the report. Update 1, 03/30/2004: a follow up report was received from a consumer indicating that he had experienced influenza, coughing and a stiff neck/shoulder almost continually since receiving Fluvirin on 10/10/2003. On 3/4/2004, the vaccinee attended an emergency room for chest pain du to excessive coughing. The reporter indicated that the doctor came to the conclusion that the vaccinee's chest wall had gone into spasm due to coughing. The vaccinee also attended a doctor on 02/19/2004 for should spasm and pain. Update 2, 05/11/2004: A follow up report was received from a health care professional indicating that he had seen the vaccinee in the emergency room for other reasons. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Accidental overdose
Clinical narrative: A report was received from a health care professional on 10/24/2003 concerning an unspecified number of vaccinees of unknown demography who received 1 ml of the Fluvirin vaccine on 10/24/2003. The reporter was not aware of any adverse events at the time of report.  There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a consumer on 10/24/2003 concerning a 2 year old male vaccinee who inadvertently received Fluvirin on 10/17/2003. On 10/17/2003 the vaccinee, who was less than 4 years of age inadvertently received Flurvirin. The vaccinee did not experinece any untoward effects after receiving the Fluvirin. Update 1, 2/16/2004: A follow up report was received from a health care professional indicating that no adverse event had occurred at the time of reporting. There was insufficient information to determine the reporter's causality assessment. No follow up pending, all information received.
Age: 48.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site mass, Pain
Clinical narrative: A report received from a consumer on 10/27/2003 concerning a 48 year old female vaccinee who was administered a brand unspecified influenza vaccine via an unlicensed rout developed an injection site bump, and had a sore arm on the same day of receiving influenza vaccine on 10/17/2003. On 10/17/2003, the vaccinee was administered influenza vaccine subcutaneously, developed an injection site bump, and had a sore arm. The injection site bump and sore arm resolved on 10/27/2003. Update 1, 05/06/2004: Further information was received from a consumer indicating that she was not administered the influenza vaccine by her primary physician therefore her physician was unable to fill out the health professional form. No follow up pending, no further information available.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 1/24/2003 concerning a 2 year old male vaccinee who inadvertently received Fluvirin on 10/17/2003. On 10/17/2004 the vaccinee, who was less than 4 years of age inadvertently received Fluvirin. The vaccinee did not experience any untoward effects after receiving the Fluvirin. There was insufficient information to determine the reporter's causality assessment. Update 11/27/2003: Follow up information was received from a health care professional on 11/27/2003 indicating that no sequelae was noted following vaccination. No follow up pending.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Rash, Urticaria
Clinical narrative: A report was received from a health care professional on 10/24/2003 concerning an octogenarian female who experienced rash and hives on her upper body and chest tightness 2 days after receiving Fluvirin on 10/22/03. On 1/24/2003 the vaccinee experienced rash and hives on her upper body and also chest tightness after she used her inhaler (type of medication unknown). She was prescribed loratadine, diphenhydramine hydrochloride, and prednisone (if condition worsened). The vaccinee had no known drug allergies and received the influenza vaccine in the past without any problems. The vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 11/27/2003: Follow up information received from a health care professional indicated that the 71 year old female vaccinee with generalized hives recovered on 11/27/2003.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/24/2003 concerning a 31 month old female vaccinee who was inadvertently administered Fluvirin vaccine on 10/21/2003. No adverse effects were associated with this inadvertent administration. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/12/2003: Follow up information received from a health care professional indicated that the vaccinee did not experience any adverse reaction. No follow up pending, all information received.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 10/24/2003, concerning a 32 year old female vaccinee who was pregnant when she received Fluvirin on 10/22/2003. On 10/22/2003, the vaccinee received Fluvirin and subsequently reported she was approximately 5 weeks pregnant when vaccinated. No adverse event was reported at the time of this report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Accidental overdose, Medication error
Clinical narrative: A report was received from a health care professional on 10/24/2003 concerning three female vaccinees of unknown age who were inadvertently administered last years vaccine (2002-2003) on an unknown date. No adverse reactions had occurred at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/10/2003: Follow up report was received from a health care professional on 12/10/2003 which indicated that a 35 year old female vaccinee inadvertently received 1 ml of expired Fluvirin on 10/23/2003. No adverse events were reported to date. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site oedema, Injection site pain
Clinical narrative: A report was received from a health care professional on 10/24/2003 concerning a female vaccinee of approximately 75 years of age who experienced redness, swelling and pain at and below the injection site 3 hours after receiving Fluvirin on 10/23/2003. On 10/23/2003 the vaccinee experienced redness, swelling and pain at and below the injection site. The swelling was up to half size of an orange. The reporter was uncertain of the vaccinee's condition at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Accidental overdose, Medication error
Clinical narrative: A report was received from a health care professional on 10/28/2003 concerning approximately 10 vaccinees of unknown demography who received a double dose of Fluvirin on 10/28/2003. No adverse events were reported at the time of this report. There was insufficient information to determine the reporter's causality assessment. Update 1, 03/01/04: Follow up information received from a health care professional indicated that none of the vaccinees experienced any adverse events. No follow up pending.
Age: 23.0
Sex: F
Vaccine: FLU3
Symptoms: Dermatitis acneiform, Pruritus, Rash erythematous
Clinical narrative: A report was received from a health care professional on 10/28/03 concerning a 23 year old female vaccinee who experienced fluid filled spots that were red, itchy and raised on the day after receiving Fluvirin on 10/20/03. On 10/21/03 the vaccinee experienced fluid filed spots that were red, itchy and raised. The vaccinee had not recovered at the time of the report. There was insufficient information to determine that reporter's causality assessment. Follow up pending. Update 1, 12/11/03: A follow up report was received from a health care professional regarding the rash which was described as covering the torso, arms, legs and head and which was pimple like. The follow up report indicated that the spots eventually dried and disappeared. It has taken several weeks for them to disappear. No further follow up necessary.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/28/2003 concerning a 44 year old female vaccinee who inadvertently received expired Fluvirin on 10/28/2003. The vaccinee had not experienced any adverse effects at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: A report was received from a health care professional on 10/28/2003 concerning a 64 year old female vaccinee who experienced pruritis 2 days days after receiving Fluvirin on 10/01/03. On 10/03/03, the vaccinee experienced pruritis on both arms, back and chest 2 days after receiving Fluvirin. The vaccinee went to the nurse on 10/27/03 about itching since the pruritis had continued for 3 weeks. Antihistamines were prescribed for the vaccinee. At the time of reporting the vaccinee had not recovered and it was unknown whether the antihistamines have helped relieve the pruritis. The reporter has assessed the  relationship of the vaccine to the event was unrelated due to the nature of the event and since the vaccinee has been receiving the influenza vaccination every year for many years with no adverse events. Update 1, 12/05/2003: Follow up information received from a health care professional on 12/05/2003, which indicated that the vaccinee also experienced hives and urticaria 1 and a half days after receiving Fluvirin. The vaccinee was treated with hydroxyzine panoate and chlorhexidine gluconate. The vaccinee recovered from the urticaria and hives on 10/31/2003. It was not reported if the vaccinee had recovered from the pruritis. The reporter has assessed the relationship of the Fluvirin to urticaria and hives as possible. Update 2, 1/23/2004: A follow up letter was received from a health care professional indicating that the pruritis had resolved on 10/31/2003. No follow up pending, all information received.
Age: 40.0
Sex: M
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: A report was received from a health care professional on 10/28/2003 concerning a 40 year old male vaccinee who experienced pruritic urticaria 12 hours after receiving Fluvirin on 10/27/2003. On 10/28/2003, the vaccinee experienced pruritic urticaria on both his legs and arms 12 hours after receiving Fluvirin. The vaccinee took Clarinex which alleviated the symptoms. The vaccinee has received influenza vaccinations in the past without any difficulties. At the time of the report the vaccinee had not recovered. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1, 01/05/04: A follow up report was received from a health care professional concerning a vaccinee who developed urticaria after receiving Fluvirin on 10/27/2003. The follow up report indicated that the patient stated on 10/29/03 the family members (who did not have the flu vaccine) also had similar "itching" in the same time frame. The reporter's causality assessment on the follow up report indicated that the adverse experience were probably not due to the flu shot. Follow up pending.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: A report was received from a health care professional on 10/28/2003 concerning a vaccinee of approximately 65 years of age who experienced overwhelming pain at the injection site immediately after receiving Fluvirin on 10/28/2003. On 10/28/2003 the vaccinee experienced overwhelming pain at the injection site after receiving 0.5ml of Fluvirin. An ice pack was applied and the pain decreased to soreness. The vaccinee had a prior history of influenza vaccination with no adverse events. The vaccinee had recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Up date 1, 03/01/2004: Follow up information received from a health car professional indicated that a 61 year old female vaccinee received Fluvirin on 10/24/2003 and experienced pain at the injection site which lasted approximately 10 minutes. No follow up pending. Cross reference with PJP20030926, PJP200300927, PJP200300928, PJP200300929, PJP200300930.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: A report was received from a health care professional on 10/28/2003 concerning a female vaccinee of unspecified age who experienced overwhelming pain at the injection site immediately after receiving Fluvirin on 10/27/2003 and injection site swelling and redness and unspecified length of time after vaccination. On 10/27/03 the vaccinee experienced overwhelming pain at the injection site. The vaccinee also experienced injection site redness and swelling on an unspecified date. An ice pack was applied and the pain decreased to soreness. The vaccinee had a prior history of influenza vaccination with no adverse events. the vaccinee had recovered at the time of the report. There was insufficient information to determine the reporters causality assessment. Update 1, 03/01/04: Follow up information received from a health care professional indicated that a 52 year old female vaccinee experienced pain at the injection site running down her arm on 10/23/03 following Flurvirin vaccination. The event lasted approximately 30 minutes and resolved on the same day. No follow up pending. Cross reference with: PJP200300925, PJP200300927, PJP200300928, PJP200300929,PJP200300930.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: A report was received from a health care professional on 10/28/2003 concerning a female vaccinee of approximately 45 years of age who experienced overwhelming pain at the injection site immediately after receiving Fluvirin on 10/24/2003. An Ice pack was applied and the pain decreased to soreness. The vaccinee had a prior history of influenza vaccination with no adverse events. The vaccinee had recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 03/01/2004: Follow up information received from a health care professional indicated that a 59 year old female vaccinee experienced pain at the injection site running down the are which lasted approximately 20 minutes. No follow up pending. Cross reference with PJP200300925, PJP200300926, PJP200300928, PJP200300929, PJP200300930.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: A report was received from a healthcare professional on 10/28/2003 concerning a female vaccinee of approximately 48 years of age who experienced overwhelming pain at the injection site immediately after receiving Fluvirin on 24 October 2003. On 24 October 2003 the vaccinee experienced overwhelming pain at the injection site.  An ice pack was applied and the pain decreased to soreness.  The vaccinee had a prior history of influenza vaccination with no adverse events.  The vaccinee recovered on an unspecified date.   There was insufficient information to determine the reporter's causality assessment. Update 1, March 2004 Follow up information received from a healthcare professional indicated that a 65 year old female vaccinee experienced pain at the injection site running down the arm which lasted approximately 15 minutes after receiving Fluvirin. No follow up pending.
Age: 15.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: A report was received from a healthcare professional on 10/28/2003 concerning a female vaccinee of approximately 16 years of age who experienced overwhelming pain at the injection site immediately after receiving Fluvirin on 10/17/2003 and injection site swelling and redness an unspecified length of time after vaccination. On 10/17/2003 the vaccinee experienced overwhelming pain at the injection site.  The vaccinee also experienced injection site redness and swelling on an unspecified date.  An ice pack was applied and the pain decreased to soreness.  The vaccinee had a prior history of influenza vaccination with no adverse events.  The vaccinee recovered on an unspecified date. There was insufficient information to determine the reporter's causality assessment. Update 1, 01 March 2004 Follow up information received from a healthcare professional indicated that a 15 year old female vaccinee experienced redness and swelling at the injection site which lasted approximately 24 hours following receipt of Fluvirin on 10/17/2004. No follow up pending.
Age: 15.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: A report was received from a healthcare professional on 10/28/2003 concerning a female vaccinee of approximately 16 years of age who experienced overwhelming pain at the injection site immediately after receiving Fluvirin on 10/17/2003. On 10/17/2003 the vaccinee experienced overwhelming pain at the injection site.  An ice pack was applied and the pain decreased to soreness.  The vaccinee had a prior history of influenza vaccination with no adverse events.  The vaccinee recovered on an unspecified date. There was insufficient information to determine the reporter's causality assessment. Update 1 01 March 2004 Follow up information received from a healthcare professional indicated that a 15 year old female vaccinee also experienced swelling and redness at the injection site which lasted 24 hours following receipt of Fluvirin. No follow up pending.
Age: 7.0
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a healthcare professional on 10/29/2003, concerned a 7 year old vaccinee of unknown sex, who received a sub-optimal dose of Fluvirin on 10/25/2003. On 25 October 2003, a 7 year old vaccinee received 0.25ml Fluvirin, instead of 0.5ml.  There were no adverse reactions reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 10/28/2003 concerning a 2 year old vaccinee of unknown sex who was inadvertently administered Fluvirin on an unknown date. On an unknown date, the vaccinee was inadvertently administered Fluvirin.  No additional information was provided at the time of the report. There was insufficient information to determine the reporter's causality assessment.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 10/28/2003 concerning a vaccinee of unspecified demography who inadvertently received two doses of Fluvirin on an unspecified date. On an unspecified date the vaccinee inadvertently received two doses of Fluvirin on an unspecified date.  It was not reported if the vaccinee had experienced an adverse reaction. There was insufficient information to determine the reporter's causality assessment. Update 1, 11/25/2003 Follow up information received from a healthcare professional indicated that a 79 year old female vaccinee was inadvertently administered Fluvirin on 10/28/2003, having previously received Fluvirin on 10/24/2003.  No adverse events were reported at the time of report.
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Fatigue, Injection site pain
Clinical narrative: A report was received from a healthcare professional on 10/29/2003 concerning a male vaccinee of unspecified age who experienced dizziness, fatigue and pain at the injection site on the night after receiving Fluvirin at 9AM on 10/28/2003. On the night of 10/28/2003 the vaccinee experienced dizziness, fatigue and pain at the injection site after receiving Fluvirin.  The symptoms had not resolved at the time of report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 10/29/2003 who is a 65 year old male vaccinee who inadvertently received expired Fluvirin on 10/29/2003. On 10/29/2003 the vaccinee inadvertently received a dose of 2002-2003 expired Fluvirin.  The vaccinee had not experienced any adverse effects at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 23 February 2004: Further information was received from a healthcare professional indicating that he experienced no adverse reaction. No follow up pending, all information received.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Rash
Clinical narrative: A report was received from a healthcare professional concerning a female vaccinee of unspecified age who experienced a rash and itching on the neck the day after receiving Fluvirin on 10/28/2003. On the 10/29/2003, the vaccinee experienced a rash and itching in the neck region.  The vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 16 February 2004. A follow up report was received from a healthcare professional indicating that the 44 year old vaccinee developed an itchy rash over arms and trunk, the day after receiving Fluvirin.  According to the reporter the event is most likely resolved as the vaccinee did not call back.  No follow up pending, no further information available.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Rash
Clinical narrative: A report was received from a healthcare professional concerning a female vaccinee of unspecified age who experienced a rash and itching on her whole body 2 days after receiving Fluvirin on 10/21/2003. On the 23 October 2003, the vaccinee experienced a rash and itching on her whole body.  The vaccinee recovered approximately 5 days later. There was insufficient information to determine the reporter's causality assessment. Update 1, 16 February 2004. A follow up report was received from a healthcare professional concerning a 37 year old vaccinee who experienced a generalized itchy rash on her arms, trunk and back on 17 October 2003, 2 days after receiving Fluvirin on 10/15/2003. According to the reporter the event is most likely resolved. No follow up pending, no further information available.
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received from a healthcare professional on 10/29/2003, concerned a 57 year old female vaccinee who accidentally received a dose of Fluvirin on 10/21/2003 and a second dose on 10/29/2003. On 10/21/2003, the vaccinee received a dose of Fluvirin and a second dose was administered on 10/29/2003.  No adverse effects have occurred at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1, 12 December 2003 The vaccinee was 56 years old at the time of the accidental overdose and received the first dose of Fluvirin on 20 October 2003.
Age: 18.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/29/2003 concerning 3 vaccinees of unknown demography who inadvertently received expired Fluvirin on an unspecified date. On an unspecified date 3 vaccinees were administered a dos of 2002-2003 Fluvirin. It was not reported if the vaccinees had experienced any adverse reaction at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 02/24/04: Follow up information received from a health care professional indicated that an 18 year old female vaccinee inadvertently received expired Fluvirin on an unspecified date in September 2003. No adverse events were reported. Follow up pending. Cross reference to PJP200400146, PJP200400147 and PJP200400148.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site hypersensitivity, Medication error, Pruritus, Thermal burn
Clinical narrative: A report was received from a health care professional on 10/29/2003 who is a 26 year old female vaccinee who experienced localized itching and burning at the vaccination site an unspecified length of time after inadvertently receiving Fluvirin subcutaneously on 10/29/2003. It was not reported if the vaccinee had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Injection site urticaria, Injection site warmth
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning an unspecified number of vaccinees of unspecified demography who experienced localized hives, swelling, redness and itching an unspecified length of time after receiving Fluvirin on an unknown date. The reporter noted many more local adverse effects than usual with the 2003-2004 Fluvirin. It was not reported if the vaccinee's had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Update 1, 02/16/2004: A follow up report was received from a health care professional indicating that a female vaccinee of unspecified age developed redness and swelling at the injection site which was warm to the touch on 10/28/03, 1 day after receiving Fluvirin on 10/27/2003. The vaccinee also developed a fever of 100F. The outcome of the adverse events was not reported at the time of reporting. Update 2, 04/16/2004: Further information was received from a health care professional which indicated that the vaccinee's symptoms resolved and no further symptoms were reported as of April 2004. No follow up pending, all information received. Cross reference with: PJP200400141, PJP200400142, PJP200400143, PJP200400144, PJP200400145.
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Pyrexia
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning an unspecified number of vaccinees of unspecified demography who experienced localized hives, swelling, redness and itching an unspecified length of time after receiving Fluvirin on an unknown date. The reporter noted many more local adverse effects than usual with the 2003-2004 Fluvirin. It was not reported if the vaccinee's had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Update 1, 02/16/2004: A follow up report was received from a health care professional indicating that a female vaccinee of unspecified age developed redness and swelling at the injection site which was warm to the touch on 10/28/03, 1 day after receiving Fluvirin on 10/27/2003. The vaccinee also developed a fever of 100F. The outcome of the adverse events was not reported at the time of reporting. Update 2, 04/16/2004: Further information was received from a health care professional which indicated that the vaccinee's symptoms resolved and no further symptoms were reported as of April 2004. No follow up pending, all information received. Cross reference with: PJP200400141, PJP200400142, PJP200400143, PJP200400144, PJP200400145.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning a 2 year old female vaccinee who inadvertently received Fluvirin on 10/29/03. At the time of the report no adverse effects occurred. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/10/03: Follow up information received from a health care professional indicated that the vaccinee did not experience any adverse reaction.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema
Clinical narrative: A report was received from a health care professional on 10/29/2003 concerning a 41 year old female vaccinee who experienced injection site redness 12 hours after receiving Fluvirin on 10/28/03. The vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending. See Ref.: PJP200300946, PJP200300947,PJP20030048.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Eye disorder, Injection site erythema, Injection site warmth, Pruritus
Clinical narrative: A report was received from a health care professional on 10/29/2003 concerning a 52 year old female vaccinee who experienced injection site redness and warmth on the same day and itching eyes and ears 10 hours after receiving Fluvirin on 10/28/2003. The vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update1, 04/15/2004: A follow up report was received from a health care professional indicating that the vaccinee had recovered on an unspecified date. No follow up pending all information received. See Ref.: PJP200300945, PJP200300947, PJP200300948.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Eye disorder, Injection site erythema, Injection site warmth, Pruritus
Clinical narrative: A report was received from a health care professional on 10/29/2003 concerning a 34 year old female vaccinee who experienced injection site redness and warmth 15 minutes after vaccination. Chest tightness and itching 30 minutes after vaccination. Fever in the evening of the same day as receiving Fluvirin on 10/21/03. On 10/21/2003, after receiving Fluvirin the vaccinee experienced injection site redness and warmth 15 minutes later, chest tightness and itching extending from the upper arm to the elbow and itching on the face and eyes 30 minutes later and fever of 100 degrees fahrenheit that evening. The injection site redness and warmth resolved on 10/26/2003. the vaccinee recovered on an unspecified date. There was insufficient information to determine the reporter's causality assessment. Update 1, 04/15/2004: A follow up report was received from a health care professional indicating that the redness and itching in the upper arm resolved 15 minutes and the tightness in her chest, itching eyes and itching face resolved after 30 minutes. No follow up pending, all information received. See Ref.: PJP200300945, PJP200300946, PJP200300948.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia
Clinical narrative: A report was received from a health care professional on 10/29/2003 concerning a 34 year old female vaccinee who experienced injection site redness and warmth 15 minutes after vaccination. Chest tightness and itching 30 minutes after vaccination. Fever in the evening of the same day as receiving Fluvirin on 10/21/03. On 10/21/2003, after receiving Fluvirin the vaccinee experienced injection site redness and warmth 15 minutes later, chest tightness and itching extending from the upper arm to the elbow and itching on the face and eyes 30 minutes later and fever of 100 degrees fahrenheit that evening. The injection site redness and warmth resolved on 10/26/2003. the vaccinee recovered on an unspecified date. There was insufficient information to determine the reporter's causality assessment. Update 1, 04/15/2004: A follow up report was received from a health care professional indicating that the redness and itching in the upper arm resolved 15 minutes and the tightness in her chest, itching eyes and itching face resolved after 30 minutes. No follow up pending, all information received. See Ref.: PJP200300945, PJP200300946, PJP200300948.
Age: 27.0
Sex: F
Vaccine: FLU3
Symptoms: Eye disorder, Injection site erythema, Injection site warmth, Pruritus
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning a 27 year old female vaccinee who experienced injection site redness and warmth one day after vaccination, and itching of the arms and eyes 2 days after receiving Fluvirin on 10/27/03. On 10/28/03 the vaccinee experienced injection site redness and warmth. On 10/29/03 the vaccinee experienced itching of the arms and eyes. the vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending. See Ref.: PJP200300945, PJP200300946, PJP200300947.
Age: 62.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning a 62 year old female vaccinee who inadvertently received a sub optimal dose of Fluvirin on 10/30/03. On 10/30/2003, the vaccinee inadvertently received a dose of Fluvirin where some of the vaccine dripped down her arm. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03 concerning a 2 year old male vaccinee who inadvertently received Fluvirin on 10/29/03. On 10/29/03, a vaccinee under 4 years of age inadvertently received Fluvirin vaccine. The vaccinee had not experienced any adverse reaction at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 01/02/04: Further information was received from a health care professional on 01/02/04 indicating that the vaccinee did not experience any adverse reaction. No follow up pending, all information received. See Ref.: PJP200300952.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 30 October 2003 concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 29 October 2003. On 29 October 2003, a vaccinee under 4 years of age inadvertently received Fluvirin vaccine.  The vaccinee had not experienced any adverse reaction at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 02 January 2004: Further information was received from a healthcare professional on 02 January 2004 indicating that the vaccinee did not experience any adverse reaction. No follow up pending, all information received.
Age: 81.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error, Overdose
Clinical narrative: A report was received from a healthcare professional on 30 October 2003 concerning an 81 year old male vaccinee who was administered 2 doses of Fluvirin on 29 October 2003. On 29 October 2003, the vaccinee was administered 0.5ml Fluvirin in his left deltoid and 0.5ml in his right deltoid.  The vaccinee was inadvertently administered the second dose of influenza vaccine instead of Pneumovax.  The vaccinee did not experience any adverse reactions at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 30 October 2003 concerning approximately 10 vaccinees under 4 years of age of unknown demographics who inadvertently received 0.25ml of Fluvirin on an unspecified date. On an unspecified date approximately 10 vaccinees under 4 years of age inadvertently received 0.25ml of Fluvirin.  No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 30 October 2003 concerning a male vaccinee in his forties who inadvertently received 0.5ml of expired Fluvirin on 27 October 2003. On 27 October 2003 the vaccinee inadvertently received 0.5ml of 2002-2003 Fluvirin.  No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 16 February 2004. A follow up report was received from a healthcare professional indicating that no adverse event had occurred at the time of reporting.  The vaccinee received this year's vaccine 3 weeks later. No follow up pending, all information received.
Age: 1.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 30 October 2003, concerning an unspecified number of vaccines under 4 years of age who inadvertently received Fluvirin on an unspecified date.  On an unspecified date,an unspecified number of vaccines under 4 years of age inadvertently received Fluvirin.  No adverse effects had occurred at the time of report.  There was insufficient information to determine the reporter's causality assessment.  Updated 1, 01 December 2003.  Follow- up information received from a health care professional indicated that a 1 year old male vaccine inadvertently received Fluvirin on 18 October 2003 and had not experienced any adverse event at the time of the report.  No follow-up pending, all information received.
Age: 84.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 30 October 2003 concerning a 70 year old male vaccine who inadvertently received expired Fluvirin on 30 October 2003.  On 30 October 2003 the vaccine inadvertently received a dose of Fluvirin which expired on 31 May 2003.  On adverse effects had occurred at the time of report.  There was insufficient information to determine the reporter's causality assessment.  Update 1 01, March 2004 Follow- up information received from a health care professional indicated that an 84 year old male vaccine did not experience any adverse events following receipt of expired vaccine.  No follow-up pending.
Age: 29.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: A report was received from a health care professional on 30 October 2003 concerning a 29 year old female vaccine who experienced tenderness at the site of injection the day of receiving Fluvirin, and a painful and tender arm 1 day after inadvertently receiving Fluvirin subcutaneously on 29 October 2003.  On 29 October 2003, the vaccine experienced a little hit of tenderness at the site of injection after receiving Fluvirin on the same day.  The Fluvirin was inadvertently administered subcutaneously.  On the morning of 30 October 2003, the vaccine experienced more discomfort and there was a long patch about 3 x 1 inches on the back of her left arm which was painful and tender.  The reporter indicated that the vaccine may have inadvertantly received Fluvirin subcutaneously instead of intranuscularly.  The vaccine is applying ice packs to the arm.  The patient had not recovered at the time of the event.    There was insufficient information to determine the reporter's causality assessment.  Update 1, 16 April 2004 Follow-up information received from a health care professional indicted that the vaccine experienced pain and redness of the left upper arm on 29 October 2003.  The vaccine was also treated with ibprofen and heat for 2-3 days.  These events resolved on 31 October 2003.  No follow-up pending, all information received.
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 31 October 2003 concerning a 50 year old male vaccine who inadvertently received a double dose of Fluvirin on 31 October 2003.  On 31 October 2003 the vaccine received a double dose of Fluvirin.  The vaccine had experienced no adverse reaction at the time of the report.  No follow-up pending, all information received.  There was insufficient information to determine the reporter's causality assessment.  Update 1, 17 February 2004.  A follow-up report was received from a health care professional indicating that no adverse event had occurred at the time of reporting.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 31 October 2003 concerning a 61 year old female vaccine who inadvertently received a double dose of Fluvirin on 31 October 2003.  On 31 October 2003 the vaccine received a double dose of Fluvirin.  The vaccine had experienced no adverse reaction at the time of the report.  There was insufficient information to determine the reporter's causality assessment.  Update 1, 17 February 2004.  A follow-up report was received from a health care professional indicating that no adverse event had occurred at the time of reporting.  No follow-up pending, all information received.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/31/2003 concerning a 28 year old female vaccinee who inadvertently received a double dose of Fluvirin on 10/31/2003. The vaccinee had experienced no adverse reaction at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 02/17/2004: A follow up report was received from a health care professional indicating that no adverse event had occurred at the time of reporting. No follow up pending, all information received. See ref: PJP200300960 and PJP200300961.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/31/03, concerning a 2 year old male vaccinee who was inadvertently administered Fluvirin on 10/31/03. The vaccinee had experienced no adverse effects at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update report 01/05/04: Follow up information received from a health care professional indicated that the female vaccinee was inadvertently administered 0.5ml of Fluvirin. Follow up pending.